We recently identified increased levels of BTK in naïve B cells as an overarching characteristic of systemic autoimmune diseases, including rheumatoid arthritis (RA), primary Sjögren’s syndrome (pSS), and granulomatosis with polyangiitis (GPA) [20,21]. This evidence concerns the gene BTK and rheumatoid arthritis.